Lotus Bio-Technology Development Corp.
LBTD · OTC
12/31/2017 | 9/30/2017 | 6/30/2017 | 3/31/2017 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $50 | $0 | $0 | $0 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $0 | $0 | $0 | $0 |
| Total Curr. Assets | $50 | $0 | $0 | $0 |
| Property Plant & Equip (Net) | $5 | $0 | $0 | $5 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | -$5 |
| Total NC Assets | $5 | $0 | $0 | $5 |
| Other Assets | $0 | $0 | $0 | -$5 |
| Total Assets | $55 | $0 | $0 | $0 |
| Liabilities | – | – | – | – |
| Payables | $15 | $11 | $12 | $12 |
| Short-Term Debt | $0 | $70 | $69 | $6 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $51 | $0 | $0 | $63 |
| Total Curr. Liab. | $67 | $81 | $81 | $81 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $50 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $117 | $81 | $81 | $81 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $1 | $1 | $1 | $1 |
| Retained Earnings | -$929 | -$964 | -$952 | -$949 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $867 | $882 | $870 | $887 |
| Total Equity | -$61 | -$81 | -$81 | -$61 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $55 | $0 | $0 | $5 |
| Net Debt | -$50 | $70 | $69 | $6 |